◀ Back to TP53

RAD50 — TP53

Text-mined interactions from Literome

Shin et al., Cell Growth Differ 2001 (Adenocarcinoma...) : After tetracycline withdrawal, cell death and multinucleated giant cells were observed with increased hRAD50 expression, and p21 ( WAF1/CIP1 ) but not p53 was increased
Tang et al., J Biol Chem 2002 : In response to DNA damage, ataxia-telangiectasia mutant and ataxia-telangiectasia and Rad-3 activate p53 , resulting in either cell cycle arrest or apoptosis
Song et al., Nat Cell Biol 2007 (Cell Transformation, Neoplastic...) : These acquired oncogenic properties of mutant p53 could be explained by the findings that these p53 mutants interact with the nuclease Mre11 and suppress the binding of the Mre11-Rad50-NBS1 (MRN) complex to DNA double stranded breaks ( DSBs ), leading to impaired Ataxia-telangiectasia mutated (ATM) activation
Liu et al., Anticancer Res 2011 (Breast Neoplasms) : The p53 pathway was involved in the synergism of RAD001 and carboplatin on breast cancer cell proliferation and apoptosis, since the synergistic effect was demonstrated in all tested breast cancer cell lines with wild-type p53 and the use of p53 inhibitor partially antagonized the effect of RAD001 and carboplatin on p53 and p21 expression, as well as their inhibitory effect on cell proliferation
Ghosh et al., J Radiat Res 2012 (Neutropenia...) : The results demonstrated that Ex-RAD ameliorates radiation induced peripheral blood cell depletion, promotes bone marrow recovery, reduces p53 signaling in spleen and protects intestine from radiation injury